OPEN END TURBO PUT-OPTIONSSCHEIN MIT SL - ZOETIS | Market Closed - Bid/Ask 01:20:50 10/05/2024 am IST | ||
| 3.81 EUR | -7.30% |
|
| Current month | -16.31% | ||
| 1 month | -1.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 3.81 | -7.30% | 0 |
| 08/24/08 | 4.11 | +12.30% | 0 |
| 07/24/07 | 3.66 | -10.73% | 0 |
| 06/24/06 | 4.1 | +7.33% | 0 |
| 03/24/03 | 3.82 | -1.04% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 10, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | 
Société Générale
|
| WKN | SU52U4 |
| ISIN | DE000SU52U49 |
| Date issued | 20/12/2023 |
| Strike | 209.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.03 € |
|---|---|
| Lowest since issue | 0.74 € |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
164.9
USD
Average target price
211
USD
Spread / Average Target
+27.93%
- Stock Market
- Certificates
- Certificat